ADS Analytics is a team of analysts with experience in research and trading departments at several industry-leading global investment banks. They focus on generating income ideas from a range of security types including: CEFs, ETFs and mutual funds, BDCs as well as individual preferred stocks and baby bonds.Analyst’s Disclosure:I/we have a beneficial long position in the shares of NCDL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinion ...

As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading, or informational reasons. For this purpose, I am not a classical equity researcher from the financial sector, but, I come from the IT world as the Director of Keylogin InfoTech and my insights are based on my own experience investing for 25 years.Also, my research is often backed by analytics and I make frequent use of charts to support my position.Based on losses during the GFC, I am ...

On Friday, Takeda Pharmaceutical Co Ltd's TAK stock wobbled after touching as low as $14.53 during the premarket session, before bouncing back to about $15.47 at last check Friday.On Thursday, the U.S. Food and Drug Administration (FDA) approved Ionis Pharmaceuticals, Inc.'s IONS Dawnzera (donidalorsen) for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.Investors should note that Takeda also has a hereditary angioedema prevention drug, ...

Key Takeaways Q2 EPS of $1.56 beat estimates, but dipped 1.9% YoY due to tariffs.Sales rose 5% YoY to $5.53B; comps improved 2%, led by cosmetics segment and Southeast & Midwest region.Stronger sales trends lift ROST's Q2, but tariff costs curbed EPS growth; management guides caution into Q3.Ross Stores, Inc. (ROST) reported second-quarter fiscal 2025 results with earnings beating the Zacks Consensus Estimate, though sales fell slightly short. Net sales rose compared with the prior year, but earnings per sh ...

Friday, August 22, 2025A half hour after the opening bell for the final trading day of the week, Fed Chair Jerome Powell will take the stage at the Jackson Hole Economic Symposium this morning, in one of his most anticipated Jackson Hole speeches in years. Investors will be listening closely to hear if the deliberate and methodical Powell will be leaning toward a 25-basis-point (bps) interest rate cut.The Fed has kept rates steady year-to-date at 4.25-4.50%. In historical terms, we’re neither high nor low — ...

PHILADELPHIA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Investor Deadline: Investors who purchased or acquired Hims & Hers securities between April 29, 2025 and June 22, 2025 (the “Class Period”) may, no later than August 25, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK ...

It has been quite a while since I last covered Qualcomm Incorporated ( QCOM ). Back in mid-February, I reiterated my buy rating on the stock, citing undervaluation and their strong position in edge AI. SinceI'm a full-time investor with a strong focus on the tech sector. I graduated with a Bachelor of Commerce Degree with Distinction, major in Finance. I'm also a proud lifetime member of the Beta Gamma Sigma International Business Honor Society. My core values are: Excellence, Integrity, Transparency, & Res ...

Key Takeaways Semtech expects Q2 revenues of $256M, up 18.9% year over year, with EPS of 40 cents.Strength across infrastructure, wireless, and high-end-consumer markets is likely to aid results.Demand for 5G modules, AI-driven data center products, and LoRa devices may boost performance.Semtech Corporation (SMTC) is scheduled to report second-quarter fiscal 2025 results on Aug. 25.For the fiscal second quarter, Semtech anticipates revenues to be $256 million (+/- $5 million). The Zacks Consensus Estimate f ...

Daniel Mellado is an economist from Carabobo University with a Master's Degree in Statistics from Simon Bolivar University, both obtained in Venezuela.Daniel worked analyzing the agricultural commodity market and the financial investment portfolio for an agribusiness group. Then, he managed two teams, one in trading and the other in data analysis. The trading team invested in bonds, equities, and ETFs.His following job opportunities have been as a freelance developing and implementing strategies for algorit ...

Despite the significant decline in crude oil prices, Devon Energy (NYSE: DVN ) has been able to sustain its FCF yield compared to the beginning of the year. This has helped support the stock to maintain nearly equivalent levels since II am a Licensed Professional Engineer who works in the Nuclear Power industry. I use my professional working knowledge of the power/energy industries to aid in evaluating potential equities worthy of long-term investment. I invest in income producing equities and rental real e ...